Goodwin advised Paindrainer AB on its commercial partnership agreement with Dr. Edward Rubin. Paindrainer AB announced a commercial partnership agreement with Dr. Edward Rubin, Past President of...
Paindrainer AB’s Partnership with Dr. Edward Rubin
STALICLA’s In-Licensing Agreement with Novartis
Goodwin Procter advised STALICLA SA on the deal. STALICLA SA announced its exclusive in-licensing agreement with Novartis to develop mavoglurant as a treatment for substance-use disorder, neurodevelopmental...
Envisagenics’ Research Collaboration Agreement with Bristol Myers Squibb Company
Goodwin Procter advised Envisagenics, Inc. on the deal. Envisagenics, Inc. announced a research collaboration agreement with Bristol Myers Squibb Company (NYSE: BMY). The multi-year collaboration will leverage...
STALICLA’s In-licensing of SFX-01
Goodwin Procter advised STALICLA on the deal. STALICLA announced its worldwide in-licensing of SFX-01, a patented composition of synthetic sulforaphane and alpha-cyclodextrin, from Evgen Pharma in neurodevelopmental...
Byggfakta Group’s IPO
Goodwin Procter and Vinge advised Byggfakta Group on the deal, while White & Case advised the underwriters. Byggfakta Group HQ AB announced a Swedish public offering with...
Femasys’ $34.45 Million IPO
Goodwin Procter advised the underwriters on the deal, while Dechert advised Femasys. Chardan, a global investment bank, announced that it acted as lead left bookrunner in...
Kojin Therapeutics’ $60 Million Series A Financing
Goodwin Procter LLP advised Cathay Health, Polaris Partners, and Newpath Partners on the deal. Cathay Health, Polaris Partners, and Newpath Partners lead the Kojin Therapeutics’ $60 Million Series...
Envisagenics’ Collaboration with Biogen Inc.
Goodwin Procter LLP advised Envisagenics on the deal. Envisagenics announced its collaboration with Biogen Inc. (Nasdaq: BIIB) to advance ribonucleic acid (RNA) splicing research within central nervous...
Olink Holding AB’s $264.7 Million IPO
Goodwin Procter LLP and Advokatfirman Delphi advised Olink Holding AB on the deal, while Baker McKenzie legal advisor to minority selling shareholders. Sweden-based Olink Holding AB...